VRTX Return on Tangible Equity | VERTEX PHARMACEUTICALS INC / MA

VERTEX PHARMACEUTICALS INC / MA (VRTX) Return on Tangible Equity

2026-06-30: Return Tang Equity 23.28%.
2026-03-31: Return Tang Equity 24.05%.
2025-12-31: Return Tang Equity 22.80%.
2025-09-30: Return Tang Equity 22.98%.

Complete source-backed return tang equity history.

Available history: 2008-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	23.28%
2026-03-31	24.05%
2025-12-31	22.80%
2025-09-30	22.98%
2025-06-30	22.95%
2025-03-31	-6.52%
2024-12-31	-3.55%
2024-09-30	-3.35%
2024-06-30	-3.64%
2024-03-31	23.34%
2023-12-31	22.27%
2023-09-30	22.49%
2023-06-30	23.40%
2023-03-31	24.43%
2022-12-31	25.90%
2022-09-30	27.38%
2022-06-30	29.22%
2022-03-31	24.75%
2021-12-31	25.74%
2021-09-30	25.52%
2021-06-30	24.31%
2021-03-31	34.62%
2020-12-31	35.29%
2020-09-30	37.73%
2020-06-30	31.93%
2020-03-31	27.68%
2019-12-31	23.15%
2019-09-30	44.61%
2019-06-30	44.13%
2019-03-31	46.12%
2018-12-31	47.82%
2018-09-30	22.66%
2018-06-30	15.76%
2018-03-31	9.61%
2017-12-31	13.32%
2017-09-30	11.25%
2017-06-30	16.03%
2017-03-31	12.23%
2016-12-31	-10.13%
2016-09-30	-22.52%
2016-06-30	-29.54%
2016-03-31	-44.05%
2015-12-31	-62.54%
2015-09-30	-75.62%
2015-06-30	-86.93%
2015-03-31	-75.25%
2014-12-31	-71.35%
2014-09-30	-46.01%
2014-06-30	-41.33%
2014-03-31	-30.79%
2013-12-31	-33.58%
2013-09-30	-45.83%
2013-06-30	-38.63%
2013-03-31	-70.85%
2012-12-31	-11.05%
2012-09-30	12.82%
2012-06-30	40.37%
2012-03-31	33.05%
2011-12-31	3.91%
2011-09-30	-56.65%
2011-06-30	-269.85%
2011-03-31	-209.39%
2010-12-31	-157.91%
2010-09-30	-117.45%
2010-06-30	-84.08%
2010-03-31	-66.85%
2009-12-31	-60.00%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	22.80%
2024-12-31	-3.55%
2023-12-31	22.27%
2022-12-31	25.90%
2021-12-31	25.74%
2020-12-31	35.29%
2019-12-31	23.15%
2018-12-31	47.82%
2017-12-31	13.32%
2016-12-31	-10.13%
2015-12-31	-62.54%
2014-12-31	-71.35%
2013-12-31	-33.58%
2012-12-31	-11.05%
2011-12-31	3.91%
2010-12-31	-157.91%
2009-12-31	-60.00%
2008-12-31	-192.51%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
PFIZER INC (PFE)	United States	$162.042B	31.94
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64